Regenxbio
RGNX
RGNX
183 hedge funds and large institutions have $1.26B invested in Regenxbio in 2018 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 86 increasing their positions, 49 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
42% less capital invested
Capital invested by funds: $2.16B → $1.26B (-$901M)
42% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 43
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
183
Holding in Top 10
2
Calls
$10.6M
Puts
$11.7M
Top Buyers
| 1 | +$25.1M | |
| 2 | +$24.4M | |
| 3 | +$11.7M | |
| 4 |
HCM
Highline Capital Management
New York
|
+$9.09M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$8.26M |
Top Sellers
| 1 | -$20.8M | |
| 2 | -$17.2M | |
| 3 | -$13.3M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$12.6M |
| 5 |
Millennium Management
New York
|
-$9.83M |